Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Merck KGaA
Biotech
Protara gears up for next commercial steps—Chutes & Ladders
Protara gears up for next steps with commercial pro. Instil installs Big Pharma vet as CMO. Orca hauls in Carvykti commercial leader.
Darren Incorvaia
,
Zoey Becker
Jun 6, 2025 8:30am
Merck KGaA posts tumor data ahead of showdown with Daiichi, Ono
May 28, 2025 8:45am
After setback, Merck KGaA shows data justifying lupus ph. 3 push
May 21, 2025 9:50am
German program matches lost NIH grants with pharma funders
Apr 7, 2025 10:50am
Merck KGaA pays $85M for global rights to Abbisko's tumor drug
Apr 1, 2025 7:40am
Merck KGaA fails lupus trial arm, plans further development
Mar 6, 2025 7:25am